OTC Cough, Cold & Allergy Medicine Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Published on : Jul-2017 | List of Tables : 244 | No. of Pages : 170 | Report Code : FACT71MR |

Very few individuals consult doctors for common conditions such as cold, cough and allergies; most of them opt for OTC medicines instead.  In the view of such prominent practices, the global sales of the OTC cough, cold and allergy medicines have remained propped up for the past decade or so. Cough, cold and allergy medicines are one of most common OTC (over-the-counter) categories, however, physicians recommend their use only for minor health issues. In many countries, there are certain laws enforced on directs sales of these medicines in order to ensure consumer safety.  In addition, these medicines offer extreme convenience to a modern consumer, living a fast-paced life. The aforementioned factors are expected to reflect favorably on the global OTC cough, cold and allergy medicines market over the next five years. Moreover, an increasing number of immunosuppressed individuals and rising global geriatric population is also expected to further drive the demand OTC medicines for cough, cold and allergy.  The recent study conducted by Fact.MR reveals that the global OTC cough, cold and allergy medicine market is poised to increase at a CAGR of 4.9% during 2017 to 2022 to reach a valuation of around US$ 37,300 Mn.

Market Taxonomy

Drug Type

OTC Channel

Dosage

Antihistamine

Pharmacy

Liquid

Expectorants

Drug Store

Capsule

Bronchodialators

Modern Trade

Tablet

Antibiotics

Online

Lozenges

Others

Other OTC Format

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Asia-Pacific excluding Japan (APEJ) to Remain the Largest Market for OTC Cough, Cold and Allergy Medicines

Asia-Pacific excluding Japan (APEJ) is projected to remain the most lucrative market for OTC cough, cold and allergy medicines throughout the forecast period. In terms of revenue, APEJ is anticipated to account for an impressive share of the global market in 2017 and beyond. The region’s proximity to air pollution has led to the rise in prevalence of various respiratory disorders. Moreover, acceptance rate of OTC medicines is extremely high in the region owing to their low cost and convenience of purchase.

By drug type, antihistamine is projected to account for more than one-third share of the market in terms of revenue by 2017-end. Antihistamines drugs reduce the release of histamine from histamine-1 receptors and are commonly used for treating allergic reactions such as inflammation (redness), swelling (edema), watery eyes or runny nose and sneezing.

Pharmacies will remain the leading OTC channel for sales of cough, cold and allergy medicines during the assessment period.  Meanwhile, drug store OTC channel segment is expected to account for the second largest revenue share of the market by 2017-end.

By dosage, the tablet segment is estimated to account for more than 33% revenue share of the market and is expected to reach a valuation of around US$ 12,400 Mn towards the end of the forecast period.

Competition Tracking

Key companies profiled in Fact.MR’s report include Sanofi-Aventis, Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZaneca Plc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Prestige Brands Holdings, Inc., Procter & Gamble Co., Bristol-Myers Squib Co., Merck & Co., and Allergen. Many of these market players are actively focusing on increasing their market presence and development of more efficient products.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Majority of OTC cough, cold and allergy medicines manufacturers are actively focusing on raising the standards of functionality and effectiveness of their products. Growing consumer awareness and introduction of more effective anti-inflammatory drugs is facilitating the growth of the global OTC cough, cold and allergy medicines market. A recent report by Fact.MR provides in-depth analysis of the global OTC cough, cold and allergy medicine market for the forecast period 2017-2022, and offers pragmatic insights to lead market players towards devising & implementing informed strategies. 

Scope

The scope of Fact.MR’s report is to analyze the global OTC cough, cold and allergy medicines market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. OTC cough, cold and allergy medicine manufacturers, suppliers and stakeholders in the global market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading magazines and journals pertaining to health and wellness.   

Summary

The report commences with a brief information of the global OTC cough, cold and allergy medicines market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global OTC cough, cold and allergy medicines market.     

Overview

The next section offers an overview of the global OTC cough, cold and allergy medicines market. This comprises an introduction to the market, along with a standard definition of OTC cough, cold and allergy medicines. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.       

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global OTC cough, cold and allergy medicines market, the report provides updates on market opportunities, which can benefit leading manufacturers of OTC cough, cold and allergy medicines.  With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for OTC cough, cold and allergy medicines manufacturers to formulate key business strategies. Detailed information on product sourcing, pricing analysis, cost structure, list of market players is provided in this section.      

Considering the wide scope of the global OTC cough, cold and allergy medicines market and to offer in-depth insights, Fact.MR’s report provides segment-wise analysis and forecast. The OTC cough, cold and allergy medicines market has been categorized on the basis of drug type, OTC channel, dosage, and region. This segmentation analysis is comprehensive, coupled with a detailed country-wise forecast provided on all parameters.      

The report’s last section comprises of the global OTC cough, cold and allergy medicines market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global OTC cough, cold and allergy medicines market.    

Research Methodology  

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Our Clients

OTC Cough, Cold & Allergy Medicine Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022